Antiplatelet drug

(redirected from Antiplatelet medication)

Antiplatelet drug

Drug that inhibits platelets from aggregating to form a plug. They are used to prevent clotting and alter the natural course of atherosclerosis.
References in periodicals archive ?
The patient was treated as unstable angina at that time and was discharged with single antiplatelet medication. He was then subjected to exercise stress test a few months later, and the result was inconclusive.
The researchers found treatment with antiplatelet medication was not more hazardous for people who already had microbleeds in their brain.
"You will likely need to be started on a light blood thinner, such as aspirin or other antiplatelet medication, and a statin," says Dr.
A low dose of aspirin, at 75-81 milligrams (mg) per day, can be used as an antiplatelet medication, to prevent blood clots from forming.
Clopidogrel (Plavix) and Prasugrel is antiplatelet medication used in patients following myocardial infarction, ischaemic stroke and ischaemic vascular disease.
Bass et al., "Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery," Ophthalmology, vol.
Caption: FIGURE 1: P-selectin in response to arachidonic acid (AA, aspirin test), by antiplatelet medication taken prior to randomisation.
When an anticoagulant or antiplatelet medication is interrupted prior to a dental procedure, there is an increased risk for thromboembolic events.
Most patients who are known to be at elevated risk for heart attack or stroke are placed on some kind of antiplatelet medication to lower their likelihood of developing an artery-blocking clot.
The authors concluded that routine dental extractions can be safely performed in patients on long-term antiplatelet medication with no interruption or alteration of their medication.
The American Heart Association (AHA) and the American College of Cardiology (ACC) in their latest guideline cited ticagrelor, an antiplatelet medication (P2Y12 inhibitor), as a preferred drug for patients with certain ACS.
Since the goal of this study was to assess association of oral anticoagulant or antiplatelet medication in BCG treated patients with prognosis, all papers not reporting any outcome correlations were excluded.